Lonza Group Ag Cash on Hand 2012-2023 | LZAGY
Lonza Group Ag cash on hand from 2012 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Lonza Group Ag cash on hand for the quarter ending December 31, 2023 was $1.858B, a 237.85% increase year-over-year.
- Lonza Group Ag cash on hand for 2022 was $2.331B, a 33.1% decline from 2021.
- Lonza Group Ag cash on hand for 2021 was $3.484B, a 559.82% increase from 2020.
- Lonza Group Ag cash on hand for 2020 was $0.528B, a 3.87% increase from 2019.
| Lonza Group Ag Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2022 | $2,331 |
| 2021 | $3,484 |
| 2020 | $528 |
| 2019 | $508 |
| 2017 | $487 |
| 2016 | $278 |
| 2015 | $288 |
| 2014 | $229 |
| 2013 | $330 |
| 2012 | $458 |
| 2011 | $222 |
| Lonza Group Ag Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2023-12-31 | $1,858 |
| 2022-12-31 | $2,331 |
| 2022-06-30 | $2,522 |
| 2021-12-31 | $3,484 |
| 2021-06-30 | $550 |
| 2020-12-31 | $528 |
| 2020-06-30 | $578 |
| 2019-12-31 | $508 |
| 2019-06-30 | $412 |
| 2018-12-31 | $471 |
| 2018-06-30 | $495 |
| 2017-12-31 | $487 |
| 2017-06-30 | $3,236 |
| 2016-12-31 | $278 |
| 2016-06-30 | $265 |
| 2015-12-31 | $288 |
| 2015-06-30 | $238 |
| 2014-12-31 | $229 |
| 2014-06-30 | $309 |
| 2013-12-31 | $330 |
| 2013-06-30 | $292 |
| 2012-12-31 | $458 |
| 2012-06-30 | $297 |
| 2011-12-31 | $222 |
| 2011-06-30 | $113 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $43.132B | $7.478B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.435B | 23.89 |
| Stryker (SYK) | United States | $127.230B | 30.47 |
| Medtronic (MDT) | Ireland | $113.715B | 16.10 |
| Boston Scientific (BSX) | United States | $109.372B | 34.84 |
| EssilorLuxottica (ESLOY) | France | $101.565B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.219B | 27.90 |
| ResMed (RMD) | United States | $32.315B | 30.34 |
| Terumo (TRUMY) | Japan | $26.460B | 37.37 |
| Koninklijke Philips (PHG) | Netherlands | $25.501B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.940B | 15.93 |
| Baxter (BAX) | United States | $17.922B | 12.74 |
| Insulet (PODD) | United States | $12.984B | 57.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.301B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.436B | 27.59 |
| BellRing Brands (BRBR) | United States | $7.595B | 35.72 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.01 |
| Haemonetics (HAE) | United States | $4.815B | 23.82 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.103B | 12.44 |
| Envista Holdings (NVST) | United States | $3.288B | 13.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.244B | 15.44 |
| QuidelOrtho (QDEL) | United States | $2.946B | 16.35 |
| Neogen (NEOG) | United States | $2.905B | 27.94 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.791B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.760B | 54.67 |
| TG Therapeutics (TGTX) | United States | $2.692B | 75.74 |
| ICU Medical (ICUI) | United States | $2.589B | 22.85 |
| Agios Pharmaceuticals (AGIO) | United States | $1.987B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.828B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.744B | 51.10 |
| Warby Parker (WRBY) | United States | $1.600B | 0.00 |
| InMode (INMD) | Israel | $1.565B | 8.32 |
| Owens & Minor (OMI) | United States | $1.462B | 12.74 |
| AdaptHealth (AHCO) | United States | $1.312B | 9.75 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| AtriCure (ATRC) | United States | $1.077B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.926B | 0.00 |
| Evolus (EOLS) | United States | $0.858B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.767B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.728B | 15.50 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.623B | 14.65 |
| Valneva SE (VALN) | France | $0.614B | 0.00 |
| PetIQ (PETQ) | United States | $0.583B | 19.05 |
| TerrAscend (TSNDF) | Canada | $0.525B | 0.00 |
| Jin Medical (ZJYL) | China | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.486B | 30.43 |
| ZimVie (ZIMV) | United States | $0.463B | 39.49 |
| Aurora Cannabis (ACB) | Canada | $0.415B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.387B | 12.45 |
| Cerus (CERS) | United States | $0.362B | 0.00 |
| Biote (BTMD) | United States | $0.362B | 8.34 |
| Zynex (ZYXI) | United States | $0.350B | 47.83 |
| MacroGenics (MGNX) | United States | $0.321B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 27.19 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.66 |
| Ayr Wellness (AYRWF) | United States | $0.222B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.210B | 0.00 |
| Veru (VERU) | United States | $0.201B | 0.00 |
| Omeros (OMER) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.179B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.167B | 80.00 |
| Quipt Home Medical (QIPT) | United States | $0.145B | 0.00 |
| InterCure (INCR) | Israel | $0.143B | 24.19 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 18.29 |
| Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 8.54 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.074B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.62 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |